Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309244417> ?p ?o ?g. }
- W4309244417 abstract "Abstract Background Among various complications of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), renal complications, namely COVID-19-associated kidney injuries, are related to the mortality of COVID-19. Methods In this retrospective cross-sectional study, we measured the sphingolipids and glycerophospholipids, which have been shown to possess potent biological properties, using liquid chromatography-mass spectrometry in 272 urine samples collected longitudinally from 91 COVID-19 subjects and 95 control subjects without infectious diseases, to elucidate the pathogenesis of COVID-19-associated kidney injuries. Results The urinary levels of C18:0, C18:1, C22:0, and C24:0 ceramides, sphingosine, dihydrosphingosine, phosphatidylcholine, lysophosphatidylcholine, lysophosphatidic acid, and phosphatidylglycerol decreased, while those of phosphatidylserine, lysophosphatidylserine, phosphatidylethanolamine, and lysophosphatidylethanolamine increased in patients with mild COVID-19, especially during the early phase (day 1–3), suggesting that these modulations might reflect the direct effects of infection with SARS-CoV-2. Generally, the urinary levels of sphingomyelin, ceramides, sphingosine, dihydrosphingosine, dihydrosphingosine l -phosphate, phosphatidylcholine, lysophosphatidic acid, phosphatidylserine, lysophosphatidylserine, phosphatidylethanolamine, lysophosphatidylethanolamine, phosphatidylglycerol, lysophosphatidylglycerol, phosphatidylinositol, and lysophosphatidylinositol increased, especially in patients with severe COVID-19 during the later phase, suggesting that their modulations might result from kidney injuries accompanying severe COVID-19. Conclusions Considering the biological properties of sphingolipids and glycerophospholipids, an understanding of their urinary modulations in COVID-19 will help us to understand the mechanisms causing COVID-19-associated kidney injuries as well as general acute kidney injuries and may prompt researchers to develop laboratory tests for predicting maximum severity and/or novel reagents to suppress the renal complications of COVID-19." @default.
- W4309244417 created "2022-11-25" @default.
- W4309244417 creator A5015097371 @default.
- W4309244417 creator A5024738150 @default.
- W4309244417 creator A5026162371 @default.
- W4309244417 creator A5029321254 @default.
- W4309244417 creator A5032342136 @default.
- W4309244417 creator A5040189891 @default.
- W4309244417 creator A5042125737 @default.
- W4309244417 creator A5048379128 @default.
- W4309244417 creator A5051917166 @default.
- W4309244417 creator A5054725382 @default.
- W4309244417 creator A5059263459 @default.
- W4309244417 creator A5060462446 @default.
- W4309244417 creator A5069646629 @default.
- W4309244417 creator A5077332068 @default.
- W4309244417 date "2022-11-10" @default.
- W4309244417 modified "2023-10-14" @default.
- W4309244417 title "Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries" @default.
- W4309244417 cites W1837355344 @default.
- W4309244417 cites W1983888208 @default.
- W4309244417 cites W1985849389 @default.
- W4309244417 cites W1988932163 @default.
- W4309244417 cites W1989066413 @default.
- W4309244417 cites W1991561847 @default.
- W4309244417 cites W2000208253 @default.
- W4309244417 cites W2014873633 @default.
- W4309244417 cites W2017729786 @default.
- W4309244417 cites W2027429767 @default.
- W4309244417 cites W2043889413 @default.
- W4309244417 cites W2064627646 @default.
- W4309244417 cites W2072716086 @default.
- W4309244417 cites W2076866060 @default.
- W4309244417 cites W2096237954 @default.
- W4309244417 cites W2101336112 @default.
- W4309244417 cites W2110127072 @default.
- W4309244417 cites W2124291383 @default.
- W4309244417 cites W2150702412 @default.
- W4309244417 cites W2558929801 @default.
- W4309244417 cites W2612514553 @default.
- W4309244417 cites W2724206069 @default.
- W4309244417 cites W2738079198 @default.
- W4309244417 cites W2801758585 @default.
- W4309244417 cites W2887269406 @default.
- W4309244417 cites W2905421366 @default.
- W4309244417 cites W2908494188 @default.
- W4309244417 cites W2909556784 @default.
- W4309244417 cites W2913918016 @default.
- W4309244417 cites W2955830011 @default.
- W4309244417 cites W2965867165 @default.
- W4309244417 cites W2977896635 @default.
- W4309244417 cites W3007757493 @default.
- W4309244417 cites W3009912996 @default.
- W4309244417 cites W3011605790 @default.
- W4309244417 cites W3012500802 @default.
- W4309244417 cites W3014061270 @default.
- W4309244417 cites W3016566297 @default.
- W4309244417 cites W3017125154 @default.
- W4309244417 cites W3018023298 @default.
- W4309244417 cites W3024011694 @default.
- W4309244417 cites W3025305522 @default.
- W4309244417 cites W3030882698 @default.
- W4309244417 cites W3034362835 @default.
- W4309244417 cites W3034521516 @default.
- W4309244417 cites W3039031817 @default.
- W4309244417 cites W3043654491 @default.
- W4309244417 cites W3046938142 @default.
- W4309244417 cites W3087671007 @default.
- W4309244417 cites W3099713540 @default.
- W4309244417 cites W3116218747 @default.
- W4309244417 cites W3124957771 @default.
- W4309244417 cites W3128480436 @default.
- W4309244417 cites W3129239028 @default.
- W4309244417 cites W3131033562 @default.
- W4309244417 cites W3134503278 @default.
- W4309244417 cites W3151400633 @default.
- W4309244417 cites W3153612641 @default.
- W4309244417 cites W3158926432 @default.
- W4309244417 cites W3164100405 @default.
- W4309244417 cites W3165244426 @default.
- W4309244417 cites W3167936456 @default.
- W4309244417 cites W3183058561 @default.
- W4309244417 cites W3183641996 @default.
- W4309244417 cites W3208478575 @default.
- W4309244417 cites W3215375003 @default.
- W4309244417 cites W4211175272 @default.
- W4309244417 cites W4213361217 @default.
- W4309244417 cites W4223979303 @default.
- W4309244417 cites W4229451861 @default.
- W4309244417 cites W4304014347 @default.
- W4309244417 doi "https://doi.org/10.1186/s12929-022-00880-5" @default.
- W4309244417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36357929" @default.
- W4309244417 hasPublicationYear "2022" @default.
- W4309244417 type Work @default.
- W4309244417 citedByCount "2" @default.
- W4309244417 countsByYear W43092444172023 @default.
- W4309244417 crossrefType "journal-article" @default.
- W4309244417 hasAuthorship W4309244417A5015097371 @default.
- W4309244417 hasAuthorship W4309244417A5024738150 @default.
- W4309244417 hasAuthorship W4309244417A5026162371 @default.